FDNA PerkinElmer, FDNA Combine Genomic Service, Phenotyping Technology to Improve Rare Disease Diagnosis Premium The firms aim to combine PerkinElmer 's Ordered Data Interpretation Network and FDNA's Face2Gene facial analysis software to target emerging markets. FDNA, PerkinElmer Form Genetic Testing Technology Alliance FDNA has developed software called Face2Gene that uses facial anomalies, phenotypic traits, and variant information to diagnose genetic disorders. Pronto Diagnostics Plans to Integrate FDNA's Phenotypic Analysis Into Its Genetic Tests The Israeli molecular diagnostics company will use artificial intelligence and phenotypic analysis to increase the diagnostic rate of its genetic tests. Vanderbilt Medical Center to Use FDNA Technology for Disease Diagnosis The Vanderbilt Center for Undiagnosed Diseases will use FDNA's Face2Gene to help evaluate difficult-to-diagnose patients. PreventionGenetics to Integrate FDNA's Face2Gene Into DNA Testing Services PreventionGenetics will use FDNA's technology to expand the diagnostic ability of its testing and interpretation services. Nov 8, 2017 FDNA Inks Deals to Improve Phenotyping Tech in Asia-Pacific Populations Nov 7, 2017 University Hospital Bonn, FDNA Expand Rare Disease Program Oct 11, 2017 FDNA, MCRI Partner to Improve Speed, Accuracy of Rare Disease Diagnosis Sep 14, 2017 Ambry Genetics, FDNA Ink Deal to Integrate Technologies Sep 6, 2017 Greenwood Genetic Center to Use FDNA Technology for Rare Disease Patient Analysis Aug 30, 2017 Variantyx, FDNA Integrate Whole Genome Tests With Phenotyping Applications Breaking News Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Metastatic Tumor Subtypes Found With Expression Profiling GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.